1,344 Shares in CME Group Inc. $CME Purchased by Waycross Partners LLC

Key Points

• Waycross Partners LLC acquired 1,344 shares of CME Group Inc., valued at approximately $370,000, marking a new investment in the company during the second quarter.
• Insider sales were notable, with General Counsel Jonathan L. Marcus selling 392 shares for nearly $102,704, bringing insider ownership down to 0.30% of total shares.
• CME Group recently declared a quarterly dividend of $1.25 per share, reflecting an annualized rate of $5.00 and a yield of 1.9%.

Waycross Partners LLC purchased a new position in shares of CME Group Inc. (NASDAQ:CME - Free Report) during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 1,344 shares of the financial services provider's stock, valued at approximately $370,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in CME. Wayfinding Financial LLC acquired a new position in CME Group during the 1st quarter worth about $25,000. Webster Bank N. A. lifted its position in CME Group by 206.9% during the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider's stock worth $25,000 after buying an additional 60 shares in the last quarter. Cornerstone Planning Group LLC lifted its position in CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after buying an additional 55 shares in the last quarter. Golden State Wealth Management LLC lifted its position in CME Group by 612.5% during the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after buying an additional 98 shares in the last quarter. Finally, Ransom Advisory Ltd acquired a new position in CME Group during the 1st quarter worth about $31,000. Institutional investors and hedge funds own 87.75% of the company's stock.

Insiders Place Their Bets

In other CME Group news, General Counsel Jonathan L. Marcus sold 392 shares of the company's stock in a transaction that occurred on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the transaction, the general counsel owned 7,851 shares of the company's stock, valued at $2,056,962. This represents a 4.76% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Sunil Cutinho sold 11,896 shares of the company's stock in a transaction that occurred on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the transaction, the insider directly owned 17,440 shares of the company's stock, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 13,043 shares of company stock valued at $3,527,956 in the last quarter. 0.30% of the stock is currently owned by insiders.

CME Group Price Performance

NASDAQ CME opened at $261.96 on Wednesday. The business has a 50 day simple moving average of $271.40 and a 200 day simple moving average of $270.80. CME Group Inc. has a 52-week low of $213.94 and a 52-week high of $290.79. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market cap of $94.41 billion, a price-to-earnings ratio of 25.36, a PEG ratio of 4.73 and a beta of 0.43.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The firm had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter in the prior year, the firm posted $2.56 EPS. The business's revenue was up 10.4% on a year-over-year basis. Analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be given a dividend of $1.25 per share. The ex-dividend date of this dividend is Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. CME Group's dividend payout ratio is 48.40%.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the stock. Barclays set a $298.00 price target on shares of CME Group and gave the stock an "equal weight" rating in a research report on Thursday, July 24th. Oppenheimer boosted their price objective on CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a report on Thursday, July 24th. Piper Sandler boosted their price objective on CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a report on Tuesday, July 15th. UBS Group dropped their price objective on CME Group from $305.00 to $285.00 and set a "neutral" rating for the company in a report on Monday, September 8th. Finally, Citigroup boosted their price objective on CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a report on Thursday, July 3rd. Four equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, CME Group presently has a consensus rating of "Hold" and a consensus target price of $260.60.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.